TEYI Pharmaceutical Group Co Ltd is well-positioned to capitalize on the growth of the Chinese traditional Chinese medicine (TCM) market, driven by government policies and increasing demand, through strategic acquisitions and expansion of production…

TEYI Pharmaceutical Group Co Ltd faces significant challenges and investor skepticism due to its declining stock price and high price-to-earnings ratio, requiring a more aggressive and innovative approach to regain market confidence.